Nagpada Police Book 2 For Selling Fake Montair-LC Tablets

The Nagpada police have booked two men, Ghulam Raju Khan and Paresh Kantilal Sakariya, for allegedly selling counterfeit Montair-LC tablets as genuine medicines. The accused were identified after an FDA probe found the drug to be spurious.

The FIR was registered on August 14, 2026, and the accused are currently under investigation. The FDA probe began on July 3, 2025, when Drug Inspector Hemant Ade received information about suspected counterfeit medicines being sold at Muskan Chemist, Kamathipura.

FDA officials seized samples of several medicines, including Montair-LC, ShelcAl 500, Chymoral Fort, Budecort Rotacaps, and ShelcAl Neu tablets. Laboratory analysis found the Montair-LC sample to be of poor quality, with only 73.26% of the labelled Levocetirizine Hydrochloride and no detectable Montelukast Sodium.

Khan allegedly sourced the medicines from Sakariya Pharma, which is owned by Paresh Kantilal Sakariya. However, Sakariya failed to provide purchase and supply details sought by the FDA. Cipla Ltd, the manufacturer of Montair-LC, later stated that the sample was counterfeit and had not originated from its manufacturing facility.

The police are currently probing the supply chain and possible involvement of others in the sale of counterfeit medicines. The investigation is ongoing, and the accused are facing charges for selling spurious drugs.

The sale of counterfeit medicines is a serious issue in India, with many people falling victim to fake drugs. The FDA and police are working together to crack down on the sale of spurious medicines and ensure that only genuine drugs are available in the market.

The incident highlights the need for stricter regulations and monitoring of the pharmaceutical industry to prevent the sale of counterfeit medicines. The police and FDA are urging people to be cautious when purchasing medicines and to only buy from authorized dealers.

The case is a significant one, and the police are working to ensure that those responsible for selling counterfeit medicines are brought to justice. The investigation is ongoing, and more details are expected to emerge in the coming days.

In conclusion, the booking of two men for selling counterfeit Montair-LC tablets is a significant step in the fight against fake medicines. The incident highlights the need for stricter regulations and monitoring of the pharmaceutical industry and the importance of ensuring that only genuine drugs are available in the market.